deuteporfin (DTBF)
/ Shanghai Fudan-Zhangjiang
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 17, 2019
Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma
(clinicaltrials.gov)
- P2; N=7; Terminated; Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.; N=50 ➔ 7; Trial completion date: May 2019 ➔ Dec 2018; Recruiting ➔ Terminated; Business Decision
Clinical • Enrollment change • Trial completion date • Trial termination
1 to 1
Of
1
Go to page
1